Sildenafil for Pulmonary Arterial Hypertension
Author:
- Sanjay MehtaSMSanjay Mehta
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Inhaled Iloprost for Severe Pulmonary HypertensionNew England Journal of Medicine, 2002
- Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial HypertensionCirculation, 2002
- Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled studyThe Lancet, 2001
- Sildenafil in Primary Pulmonary HypertensionNew England Journal of Medicine, 2000
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertensionCardiovascular Research, 1996
- Role of pharmacologic tests in the treatment of primary pulmonary hypertensionThe American Journal of Cardiology, 1995
- Expression of Endothelin-1 in the Lungs of Patients with Pulmonary HypertensionNew England Journal of Medicine, 1993
- Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertensionThe Lancet, 1991
- Vasodilators and pulmonary arterial hypertension: the paradox of therapeutic success and clinical failureInternational Journal of Cardiology, 1988